Trimetazidine SR
Trimetazidine MV is formulated to improve the metabolic functioning of heart cells, supporting cardiac efficiency without affecting heart rate or blood pressure. It is primarily used to manage symptoms of stable angina pectoris, helping reduce the frequency of angina attacks. The medication works by preserving energy metabolism in cells exposed to low oxygen conditions, thus protecting the heart muscle. Trimetazidine MV tablets offer a modified release formulation for sustained effectiveness throughout the day. This medication is typically prescribed for long-term management of heart conditions, promoting improved quality of life for patients with chronic angina. Consistent use may enhance exercise tolerance and reduce the need for additional antianginal medications.Active substance:
Trimetazidine dihydrochloridePharmachologic effect:
Trimetazidine is an anti-ischemic metabolic agent that improves myocardial glucose utilization through inhibition of fatty acid metabolism. It helps maintain energy metabolism of heart and neurosensory organs during episodes of ischemia.Indications:
- Symptomatic treatment of stable angina pectoris
- Adjunctive therapy in the management of angina
Contraindications:
- Hypersensitivity to trimetazidine or any of the excipients
- Parkinson's disease
- Movement disorders
- Severe renal impairment
Side effects:
In order of decreasing probability: Common: Dizziness, headache, Uncommon: Abdominal pain, diarrhea, dyspepsia, nausea, vomiting, Rare: Palpitations, extrasystoles, tachycardia, Very rare: Agranulocytosis, thrombocytopenia
Dosing and Administration:
The recommended dose is one tablet of Trimetazidine MR 35 mg twice daily, in the morning and evening, during meals. The dosage may be adjusted based on the patient's condition and response to treatment.
Storage:
Store at a temperature not exceeding 25°C (77°F).
Trimetazidine SR
in Cyrillic : Триметазидин МВ
SUBSTANCE
Trimetazidine
DOSAGE FORM
tablets
In Stock
available pack options :
| 35mg x 60 tablets | $27.50 |
